These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 895374)

  • 21. DOPA effects on motility in mice; potentiation by MK 485 and dexchlorpheniramine.
    Strömberg U
    Psychopharmacologia; 1970 Aug; 18(1):58-67. PubMed ID: 5535577
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of L-dopa on efflux of cerebral monoamines from synaptosomes.
    Ng KY; Colburn RW; Kopin IJ
    Nature; 1971 Apr; 230(5292):331-2. PubMed ID: 5549411
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of L-DOPA on brain polysomes and protein synthesis: probable mediation by intracellular dopamine.
    Weiss BF; Roel LE; Munro HN; Wurtman RJ
    Adv Neurol; 1974; 5():87-99. PubMed ID: 4155238
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mechanisms of regulating monoamine oxidase activity in different brain regions].
    Petrenko SV; Balakleevskiĭ AI
    Vopr Med Khim; 1980; 26(2):264-70. PubMed ID: 7456358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha1-adrenoceptors mediate dihydroxyphenylalanine-induced activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaques.
    Visanji NP; Fox SH; Johnston TH; Millan MJ; Brotchie JM
    J Pharmacol Exp Ther; 2009 Jan; 328(1):276-83. PubMed ID: 18955589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of L-dopa on behavior and on brain amines in mice treated with 6-hydroxydopamine.
    Barnes L; Cann F; Karczmar AG; Kindel G; Longo VG
    Pharmacol Biochem Behav; 1973; 1(1):35-40. PubMed ID: 4775581
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal of alpha-methyltyrosine-induced behavioural depression with dihydroxyphenylalanine and amphetamine.
    Moore KE; Rech RH
    J Pharm Pharmacol; 1967 Jun; 19(6):405-7. PubMed ID: 4382374
    [No Abstract]   [Full Text] [Related]  

  • 28. Tryptophan-induced suppression of conditioned avoidance behavior in rats.
    Engel J; Modigh K
    Adv Biochem Psychopharmacol; 1974; 11(0):405-9. PubMed ID: 4845707
    [No Abstract]   [Full Text] [Related]  

  • 29. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK; Chase TN; Colburn RW; Kopin IJ
    Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
    [No Abstract]   [Full Text] [Related]  

  • 30. Increase of catecholamines in mouse brain by systemic administration of gamma-glutamyl L-3,4-dihydroxyphenylalanine.
    Ichinose H; Togari A; Suzuki H; Kumagai H; Nagatsu T
    J Neurochem; 1987 Sep; 49(3):928-32. PubMed ID: 3112308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine.
    Benkert O; Gluba H; Matussek N
    Neuropharmacology; 1973 Mar; 12(3):177-86. PubMed ID: 4735415
    [No Abstract]   [Full Text] [Related]  

  • 32. Mescaline: its effects on learning rate and dopamine metabolism in goldfish (Carassius auratus).
    Zeller EA; Couper GS; Huprikar SV; Mellow AM; Moody RR
    Experientia; 1976 Nov; 32(11):1453-4. PubMed ID: 991995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson's disease treated with l-DOPA.
    Zhao TT; Shin KS; Kim KS; Park HJ; Kim HJ; Lee KE; Lee MK
    Neuroscience; 2016 Dec; 339():644-654. PubMed ID: 27789382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the mechanism of L-dopa-induced postural hypotension in the cat.
    Dhasmana KM; Spilker BA
    Br J Pharmacol; 1973 Mar; 47(3):437-51. PubMed ID: 4147189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
    Viala D; Buser P
    Psychopharmacologia; 1974; 40(3):225-33. PubMed ID: 4548539
    [No Abstract]   [Full Text] [Related]  

  • 36. Catecholamines, drugs, and behavior: mutual interactions.
    Seiden LS; Campbell AB
    Adv Biochem Psychopharmacol; 1974; 12(0):325-38. PubMed ID: 4418348
    [No Abstract]   [Full Text] [Related]  

  • 37. L-dopa, dopamine, and hypomania.
    Murphy DL; Goodwin FK; Brodie HK; Bunney WE
    Am J Psychiatry; 1973 Jan; 130(1):79-82. PubMed ID: 4682751
    [No Abstract]   [Full Text] [Related]  

  • 38. Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat.
    Tayarani-Binazir KA; Jackson MJ; Strang I; Jairaj M; Rose S; Jenner P
    Behav Pharmacol; 2012 Apr; 23(2):126-33. PubMed ID: 22236652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
    Schoenfeld RI; Uretsky NJ
    J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
    [No Abstract]   [Full Text] [Related]  

  • 40. Blockade of L-dopa reversal of reserpine-induced conditioned avoidance response suppression by disulfiram.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Sep; 163(1):84-90. PubMed ID: 5673718
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.